Our contention is that endogenous 5-hydroxytryptamine (5-HT) is not necessary for colonic peristalsis, nor other neurogenic motor patterns in the lower gastrointestinal (GI) tract, such as colonic migrating motor complexes (CMMCs).
Background
Large quantities of 5-hydroxytryptamine (5-HT) are synthesized in the gut, in enterochromaffin (EC) cells of the mucosa (via tryptophan hydroxylase-1) and in a small proportion in enteric neurons (via tryptophan hydroxylase-2). It has been well established that 5-HT can be released from the mucosa by mechanical stimulation, including contractile activity of the gut and compression of the gut wall (Bertrand, 2006) . Numerous 5-HT receptors are expressed on enteric neurons and extrinsic afferent endings, and exogenous 5-HT has potent effects on neuronal excitability and transmitter release (Gershon, 2000) . Despite this, the evidence that 5-HT is necessary for peristalsis or CMMCs in the lower GI-tract is all circumstantial. Extensive evidence now suggests that these motor patterns occur independent of 5-HT.
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Three lines of disputed evidence
High quantities of 5-HT are synthesized and released from the mucosa. Release of endogenous 5-HT can occur during peristalsis and CMMCs and exogenous 5-HT can evoke peristalsis or CMMCs. The observation that mucosal compression causes release of endogenous 5-HT at the same time as the onset of peristalsis or CMMCs does not reflect a causal relationship between these events. Mucosal compression distorts multiple cell types in the gut wall, including the underlying myenteric plexus -which is itself exquisitely sensitive to mechanical deformation (Kunze et al. 2000) . Compression applied to the myenteric plexus still evokes peristaltic reflexes, even after the mucosa has been removed (Spencer et al. 2003) and CMMCs also persisted in these preparations (Keating & Spencer, 2010; . Thus, while mucosal stimulation can release large amounts of endogenous 5-HT, we contend that this release is not a necessary step in initiating peristalsis or CMMCs. The observation that exogenous 5-HT (and many other agonists) can initiate peristalsis and CMMCs does not reveal any information about the functional role of endogenous 5-HT.
It has been suggested that endogenous 5-HT release from the mucosa initiates the colonic peristaltic reflex (Foxx-Orenstein et al. 1996; Grider et al. 1996) and is 'critical' for spontaneous CMMCs (Heredia et al. 2009 ). It was reported that 'removing the mucosa appeared to abolish spontaneous CMMCs, suggesting that the mucosa is normally critical for their generation' (Heredia et al. 2009 ) -a conclusion based on four mice. It was further stated that 'the trigger for the CMMC appears to be spontaneous or evoked (i.e. a fecal pellet) release of 5-HT from EC cells to stimulate AH neurons' . Although, 5-HT release from the mucosa was not measured, nor were recordings made from neurons to confirm this hypothesis. If 5-HT release from the mucosa was essential for peristalsis or CMMCs, then both these motor patterns would be expected to cease when the mucosa is removed. They don't. With practice it was demonstrated that the entire mucosa can be reliably removed from an isolated specimen of colon and still record peristalsis and spontaneous and evoked CMMCs (Keating & Spencer, 2010) . In these mucosa-free preparations, release of 5-HT that is normally associated with peristaltic or CMMC contractions was abolished. Importantly, when removing the mucosa we observed that if the dissection technique was too vigorous, the delicate neural circuitry required for peristalsis or CMMCs is disrupted. This may explain why spontaneous CMMCs were not recorded after removal of the mucosa in the four mice studied in Heredia et al. (2009) . We consider it inconceivable that dissection damage in our preparations could have created a whole new motor pattern that mimicked normal peristalsis and CMMCs.
In other studies, electrochemical detection of 5-HT release from the mucosa showed that 5-HT release was only associated with some, but not all, contractions underlying peristalsis (Bertrand, 2006) or CMMCs (Keating & Spencer, 2010) , again arguing against a causal link between 5-HT release and these colonic motor patterns. If 5-HT release from the mucosa was critical for peristalsis and CMMCs, then deleting the gene responsible for synthesizing mucosal 5-HT (TPH-1) should block CMMCs and affect transit. It doesn't. The laboratory that concluded 5-HT release from the mucosa J Physiol 593.15 was critical for CMMCs (Heredia et al. 2009 ) also showed that CMMCs still occurred when mucosal 5-HT synthesis had been prevented (Heredia et al. 2013) . Furthermore, conscious mice lacking mucosal 5-HT synthesis have no inhibitory deficits in GI-transit (Yadav et al. 2010; Li et al. 2011) .
Endogenous 5-HT is synthesized in enteric neurons and numerous 5-HT receptors are expressed in the gut. There is some evidence that 5-HT may be a neurotransmitter in a small population of myenteric (Zhou & Galligan, 1999; Galligan et al. 2000) and submucosal neurons (Monro et al. 2004 ) of the small intestine, despite only ß1% of enteric neurons expressing 5-HT (Costa et al. 1982; Wardell et al. 1994; Costa et al. 1996) . For a substance to be a neurotransmitter, it must be 'present in the presynaptic terminal and is released in amounts sufficient to exert a defined action on the postsynaptic neuron or effector organ' (Gardner et al. 2000) . Based on this criterion, we are not aware of any evidence that endogenous 5-HT participates in any synaptic potential in the colon of the mouse (Furukawa et al. 1986; Nurgali et al. 2004 ) and rarely (Nurgali et al. 2003) or never (Wade & Wood, 1988; Spencer & Smith, 2004) in the colon of the guinea-pig, which are the species we have been studying CMMCs and peristalsis with. In our experience in guinea-pig colon (Spencer & Smith, 2004) and in mouse (Furukawa et al. 1986; Nurgali et al. 2004) , human (Brookes et al. 1987) and rat colon (Brookes et al. 1988) , all fast synaptic potentials are blocked by hexamethonium.
5-HT antagonists can block peristalsis and CMMCs and retard transit.
Perhaps the strongest evidence that endogenous 5-HT is necessary for peristalsis is based on the finding that 5-HT antagonists can substantially inhibit or block colonic peristalsis (Foxx-Orenstein et al. 1996; Grider et al. 1996; Kadowaki et al. 1996) . However, when these experiments were repeated with the same antagonists (SDZ-205-557 and ondansetron) they were only found to cause a temporary blockade of peristalsis. In the continued presence of both antagonists peristalsis reappeared (Sia et al. 2013a, b) . Importantly, these antagonists also blocked peristalsis in colonic preparations from mucosa-free, reserpine-treated animals, where endogenous 5-HT had been depleted. This showed that endogenous 5-HT may not be necessary for activation of 5-HT3 and 5-HT4 receptors. We suggest that 5-HT3 and 5-HT4 antagonists bind to 5-HT3 and 5-HT4 receptors which are constitutively active even in the absence of any 5-HT. Indeed, ligand-gated 5-HT3 receptors (Hu & Peoples, 2008) and G-protein coupled 5-HT4 receptors (Berthouze et al. 2005) both show constitutive activity. These antagonists could work as inverse agonists, reducing the constitutive activity of the receptors, rather than blocking the effects of endogenous 5-HT.
At present, we are unsure of the role of 5-HT in the lower GI tract. We do know that 5-HT can have many effects and it may modulate enteric circuits and motility. However, recent evidence from a number of laboratories, using a number of techniques, shows that neither mucosal nor neuronal 5-HT is necessary for colonic peristalsis or CMMCs.
